The 'really hot stuff' from this year's Digestive Disease Week that will interest primary care providers, according to Dr David Johnson.

Dr David Johnson provides his perspective on many of the exciting scientific advances presented at this year's Digestive Disease Week.

Dr John Marshall previews the GI cancer studies being presented at ASCO with his picks for the ones to watch, and predicts that a plenary presentation may be practice-changing.

With this review of the new literature, Dr David Johnson wants to put the risks associated with proton pump inhibitors into perspective and quiet the noise.

Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care.

A possible side effect in over 700 prescriptions, drug-induced diarrhea is exceedingly common and potentially dangerous. Dr David Johnson identifies some possible culprits.

Despite many challenges, an increasing number of HCV-infected patients are being treated and cured, and many can be managed in primary care.

Here's what you need to know for adult patients who are traveling to cholera outbreak areas and who may be candidates for the new cholera vaccine.

Dr David Kerr challenges the oncology community to come up with rational, meaningful clinical trials to clarify the biology of metastatic peritoneal disease in colorectal cancer.

Previously thought to be 'anticoagulated,' patients with cirrhosis really might be hypercoagulable. Dr David Johnson explains why this paradox is a 'must understand' for all who manage this condition.